November 22, 2016 - By Clifton Ray · 0 Comments
The stock of ZEALAND PHARMA A/S (OTCMKTS:ZLDPF) registered a decrease of 46.65% in short interest. ZLDPF’s total short interest was 20,700 shares in November as published by FINRA. Its down 46.65% from 38,800 shares, reported previously. The stock closed at $16.5 during the last session. It is down 19.79% since April 25, 2016 and is downtrending. It has underperformed by 24.34% the S&P500.
More notable recent Zealand Pharma A S (OTCMKTS:ZLDPF) news were published by: Reuters.com which released: “BRIEF-Zealand Pharma announces new timelines for US FDA decision on igla…” on August 19, 2016, also Reuters.com with their article: “BRIEF-Zealand Pharma raises DKK 143 million via private placement” published on September 30, 2016, Reuters.com published: “BRIEF-Zealand Pharma: FDA approves lixisenatide in the US” on July 28, 2016. More interesting news about Zealand Pharma A S (OTCMKTS:ZLDPF) were released by: Globenewswire.com and their article: “Zealand and Beta Bionics to collaborate on the development of a first-in-class …” published on June 10, 2016 as well as Nasdaq.com‘s news article titled: “The U.S. FDA approves Soliqua(TM) 100/33 for the treatment of adults with type …” with publication date: November 22, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Clifton Ray